← Back to Search

Other

Nasogastric Balloon Placement for Respiratory Function(VIREM Trial)

The Hospital for Sick Children (SickKids), Toronto, Canada

Targeting 3 different conditionsPlacement of nasogastric balloonN/ARecruitingResearch Sponsored by University Hospital, Antwerp

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

requiring invasive mechanical ventilation

Must not have

Timeline

Screening 3 weeks

Treatment Varies

Follow Upfrom date of intubation until the date of death from any cause, whichever came first, assessed up to 4 months

Awards & highlights

No Placebo-Only Group

VIREM Trial Summary

This trial will study the effects of a patient's inspiratory effort on their lungs and diaphragm.

Eligible Conditions

Respiratory Function Tests
Respiratory Muscles
Artificial Respiration

VIREM Trial Eligibility Criteria

Inclusion Criteria

You will be eligible if you check “Yes” for the criteria below

VIREM Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ from date of intubation until the date of death from any cause, whichever came first, assessed up to 4 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~from date of intubation until the date of death from any cause, whichever came first, assessed up to 4 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and from date of intubation until the date of death from any cause, whichever came first, assessed up to 4 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Tidal esophageal pressure swing (∆Pes) - D1

Tidal esophageal pressure swing (∆Pes) - D2

Tidal esophageal pressure swing (∆Pes) - D3

+5 more

Secondary outcome measures

Dead space ventilation (VD) - D1

Dead space ventilation (VD) - D2

Continuous Positive Airway Pressure

+87 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

VIREM Trial Design

1Treatment groups

Experimental Treatment

Group I: Overall groupExperimental Treatment1 Intervention

Placement of a nasogastric balloon

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

KU LeuvenOTHER

532 Previous Clinical Trials

200,339,076 Total Patients Enrolled

Universitaire Ziekenhuizen LeuvenOTHER

849 Previous Clinical Trials

1,244,123 Total Patients Enrolled

University Hospital, AntwerpLead Sponsor

279 Previous Clinical Trials

112,871 Total Patients Enrolled

Media Library

Placement of nasogastric balloon (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05459116 — N/A

Respiratory Function Tests Research Study Groups: Overall group

Respiratory Function Tests Clinical Trial 2023: Placement of nasogastric balloon Highlights & Side Effects. Trial Name: NCT05459116 — N/A

Placement of nasogastric balloon (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05459116 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any openings left to participate in this clinical research?

"Affirmative. According to clinicaltrials.gov, this medical trial which was initially advertised on September 21st 2022 is currently recruiting participants. Approximately 150 patients need to be enrolled from a single site."

Answered by AI

What is the participant quota for this research experiment?

"Affirmative. The information hosted on clinicaltrials.gov suggests that this research project, which was first posted on September 21st 2022, is in the process of participant recruitment. 150 people are required to join from a single site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Visualization of Inspiratory Effort and Respiratory Mechanics to Promote Lung- and Diaphragm Protective Ventilation

2022. "Visualization of Inspiratory Effort and Respiratory Mechanics to Promote Lung- and Diaphragm Protective Ventilation". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05459116.